Navigation Links
Epilepsy drug shows potential for Alzheimer's treatment

A drug commonly used to treat epilepsy could help clear the plaques in the brain associated with Alzheimer's disease, according to researchers at the University of Leeds. The plaques are known to lead to the progressive death of nerve cells in the brain linked to many forms of dementia.

Sodium valproate - which is marketed as the anti-seizure drug Epilim - has been shown by scientists at the University of Leeds to reactivate the body's own defences against a small protein called amyloid beta peptide, which is the main component of the brain plaques characteristic in Alzheimer's. Their work was funded by the Medical Research Council.

"The fact that we've been able to show that a well-established, safe and relatively inexpensive drug could help treat Alzheimer's is an extremely exciting development," says lead researcher Professor Tony Turner from the University's Faculty of Biological Sciences. "We hope colleagues will be able to progress this research with clinical trials in the near future."

Alzheimer's disease is the most common form of dementia and has no cure. In the UK today there a half a million people living with Alzheimer's and this is likely to double within a generation unless new treatments are found.

Sodium valproate has been used for many years to suppress epileptic seizures and the many sufferers of epilepsy have been taking the drug for decades with few side effects.

The development of Alzheimer's is widely believed to be caused by the gradual accumulation in the brain of amyloid-beta peptide which is toxic to nerve cells. This is thought to be caused by a key enzyme called neprilysin or NEP gradually switching off in later life. One of NEP's roles is to clear the toxic peptide from the brain, and plaques begin to form as it gradually switches off, leading to the death of the brain's nerve cells.

The research team examined changes in chromatin the 'packaging' that genes are contained within - and surmised that these changes might be involved in switching off NEP. The team found clear differences (acetylation) in key proteins within the chromatin when they compared normal nerve cells against those that failed to produce NEP.

"From there it was relatively simple to stimulate the expression of NEP with sodium valproate, which was seen to prevent the acetylation," says Professor Turner. "We were elated when we saw the results."


Contact: Jo Kelly
University of Leeds

Related biology news :

1. International team discovers gene associated with epilepsy
2. Drops in blood oxygen levels may be key to sudden death in some epilepsy patients
3. Rare genetic disorder gives clues to autism, epilepsy, mental retardation
4. Brain study may lead to improved epilepsy treatments
5. Early treatment stops epilepsy in its tracks
6. Vitamin E shows possible promise in easing chronic inflammation
7. Synthetic biology: Is ethics a showstopper?
8. Study on wildlife corridors shows how they work over time
9. Cell movements totally modular, Stanford study shows
10. Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu
11. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
Post Your Comments:
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - ...
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
Breaking Biology Technology: